• Revance Therapeutics, Inc. (NASDAQ:RVNC) Receives Consensus Rating of "Hold" from Analysts

    来源: Buzz FX / 18 10月 2024 05:22:13   America/New_York


    Revance Therapeutics, Inc. (NASDAQ:RVNC) Receives Consensus Rating of "Hold" from Analysts Written by MarketBeat October 18, 2024 Share Link copied to clipboard. Shares of Revance Therapeutics, Inc. ( NASDAQ:RVNC - Get Free Report ) have re
    Read more...
分享